本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

拜瑪林製藥

59.64
-2.4200-3.90%
盤後59.640.00000.00%18:41 EDT
成交量:153.70萬
成交額:9,225.35萬
市值:114.38億
市盈率:22.05
高:62.06
開:61.95
低:59.41
收:62.06
資料載入中...
2022/05/31

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/04/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/27

重要事件披露

8-K - Current report
2022/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/23

SEC問詢函

CORRESP [Cover] - Correspondence
2022/02/23

重要事件披露

8-K - Current report
2022/02/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

重要事件披露

8-K - Current report
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/28

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/22

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/30

持股變動聲明

4 - Statement of changes in beneficial ownership of securities